Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Shares Issued (2020 - 2025)

HCW Biologics (HCWB) has disclosed Shares Issued for 6 consecutive years, with $2.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued fell 6.21% year-over-year to $2.3 million, compared with a TTM value of $4.3 million through Sep 2025, up 71.66%, and an annual FY2024 reading of $3.0 million, changed N/A over the prior year.
  • Shares Issued was $2.3 million for Q3 2025 at HCW Biologics, up from $1.5 million in the prior quarter.
  • Across five years, Shares Issued topped out at $56.0 million in Q3 2021 and bottomed at -$2.5 million in Q2 2024.
  • Average Shares Issued over 5 years is $3.5 million, with a median of $6856.0 recorded in 2022.
  • The sharpest move saw Shares Issued skyrocketed 6885158.3% in 2021, then plummeted 32546.32% in 2024.
  • Year by year, Shares Issued stood at $56.0 million in 2021, then plummeted by 99.99% to $5831.0 in 2022, then plummeted by 266.3% to -$9697.0 in 2023, then skyrocketed by 4801.09% to $455865.0 in 2024, then soared by 414.84% to $2.3 million in 2025.
  • Business Quant data shows Shares Issued for HCWB at $2.3 million in Q3 2025, $1.5 million in Q2 2025, and $1654.0 in Q1 2025.